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In recent years, the transcription factor serum response factor (SRF) was shown to con-
tribute to various physiological processes linked to neuronal motility. The latter include cell
migration, axon guidance, and, e.g., synapse function relying on cytoskeletal dynamics,
neurite outgrowth, axonal and dendritic differentiation, growth cone motility, and neurite
branching. SRF teams up with myocardin related transcription factors (MRTFs) and ternary
complex factors (TCFs) to mediate cellular actin cytoskeletal dynamics and the immediate-
early gene (IEG) response, a bona ﬁde indicator of neuronal activation. Herein, I will discuss
how SRF and cofactors might modulate physiological processes of neuronal motility. Fur-
ther, potential mechanisms engaged by neurite growth promoting molecules and axon
guidance cues to target SRF’s transcriptional machinery in physiological neuronal motility
will be presented. Of note, altered cytoskeletal dynamics and rapid initiation of an IEG
response are a hallmark of injured neurons in various neurological disorders. Thus, SRF
and its MRTF and TCF cofactors might emerge as a novel trio modulating peripheral and
central axon regeneration.
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INTRODUCTION
Serum response factor (SRF), a MADS box transcription factor
(Norman et al., 1988), was originally identiﬁed as the gene regu-
lator activated by serum stimulation of starved cells (Posern and
Treisman, 2006; Miano et al., 2007; Olson and Nordheim, 2010).
Serum response elements (SRE) recognized by SRF are present in
a wealth of genes with diverse functions, yet are enriched in two
classes of SRF target genes (Philippar et al., 2004; Selvaraj and
Prywes, 2004; Sun et al., 2006; Stritt et al., 2009):
(i) Immediate-early genes (IEGs), including genes encoding
transcription factors (Curran and Morgan, 1995; Herde-
gen and Leah, 1998), growth factors (e.g., Ctgf, Bdnf), and,
e.g., the synaptic plasticity associated gene Arc (Arg3.1). IEG
induction is a rapid – activated within minutes – but tran-
sient gene expression response, not requiring new protein
synthesis.
(ii) Many genes encoding components of the actin cytoskeleton
including actin isoforms (Actb,Actc,Actg,Acta) orABPs (actin
binding proteins; gelsolin, vinculin, transgelin, tropomyosin,
myosins, vinculin) are transcriptionally regulated by SRF.
Such a unique gene regulatory signature imposed by SRF
toward actin cytoskeletal genes has not been described for
microtubules and intermediate ﬁlaments and any other gene
regulator so far.
Besides direct transcriptional regulation, SRF controls – via a
post-translational mechanism – activity of the actin severing pro-
tein coﬁlin (Alberti et al., 2005; Mokalled et al., 2010; see also
Potential SRF and Cofactor Invoked Mechanisms Modulating
Neurite Growth and Regeneration.).
Some genes such as actin isoforms are considered to have both,
IEG properties and cytoskeletal functions (Ramanan et al., 2005;
Knoll and Nordheim, 2009).
Serum response factor recruits cofactors to mediate the two
gene responses outlined above. To convey an IEG response, SRF
mainly teams up with ternary complex factors (TCFs) such as
Elk-1, Sap-1, and Net (Sharrocks, 2001; Shaw and Saxton, 2003;
Buchwalter et al., 2004; Besnard et al., 2011). TCFs are activated by
a mitogen-activated protein kinase (MAPK) cascade upon serum
and growth factor stimulation.
As outlined above, SRF transcriptionally regulates many genes
encoding components of the actin cytoskeleton. In turn, SRF’s
activity is adjusted by actin treadmilling. In order to respond to
changes in cytoplasmic actin dynamics, SRF recruits an“actin sen-
sor”composed bymembers of themyocardin related transcription
factor family (MRTF;Pipes et al., 2006; Posern andTreisman,2006;
Olson andNordheim, 2010). Themechanismof this“actin sensor”
was investigated in most detail for MRTF-A (also named MAL) in
non-neuronal cells (Miralles et al., 2003). MRTF-A’s function as a
sensor of actin dynamics relies on its capability to bindmonomeric
actin and – at least in part – on shuttling in and out of the nucleus
(Mouilleron et al., 2008).
In un-stimulated cells, monomeric G-actin blocks MRTF-A’s
ability to augment SRF’s transcriptional activity by (i) decreasing
MRTF-A nuclear import, (ii) enhancing MRTF-A nuclear export
in an actin-dependent manner, and (iii) by a nuclear G-actin
fraction binding directly to MRTF-A (Vartiainen et al., 2007).
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Upon cell stimulation, Rho-GTPases stimulate F-actin assem-
bly and thereby a depletion of the G-actin pool. This liberates
MRTF-A from G-actin and allows, e.g., for MRTF-A nuclear
entry (Miralles et al., 2003). Notably, Rho-GTPases such as RhoA,
Cdc42, and Rac1 are important actin cytoskeletal modulators of
neuronal morphology and axonal regeneration (Tahirovic and
Bradke, 2009; Hall and Lalli, 2010). Thus, SRF might be a sig-
naling intermediate bridging the impact of Rho-GTPases on
cytoskeletal dynamics. In sum, G-actin reduces, whereas F-actin
assembly augments SRF-mediated gene activity (Posern et al.,
2002, 2004; Posern and Treisman, 2006; Knoll and Nordheim,
2009; Stern et al., 2009; Knoll, 2010; Olson and Nordheim, 2010).
This principal mechanism appears to be conserved also in neu-
rons. However, in neurons modiﬁcations to this scheme might
exist, as constitutive nuclear MRTF localization has been reported
as well as MRTF shuttling (Tabuchi et al., 2005; Kalita et al.,
2006; Wickramasinghe et al., 2008; Stern et al., 2009; Knoll,
2010).
Myocardin related transcription factors and TCFs may act
antagonistically in some instances by competing for SRF occu-
pancy as demonstrated in muscle cells (Wang et al., 2004). In
addition, a cross-talk between the upstream pathways of MRTF
and TCF activation has been shown. Here, nuclear MAL export is
facilitated by ERK1/2 phosphorylation of MAL (Kalita et al., 2006;
Muehlich et al., 2008). In contrast, ERK1/2 phosphorylation of
the TCF Elk-1 prevents nuclear export and facilitates Elk-1 import
into the nucleus. Of note, MRTF can also negatively regulate MAP
kinase signaling via regulation of the mitogen-inducible gene 6
(Mig6; Descot et al., 2009)
SRF AND ITS COFACTORS IN PHYSIOLOGICAL PROCESSES
REQUIRING NEURONAL MOTILITY
SRF FUNCTIONS IN NEURONAL MOTILITY
Up until now, the role of SRF in neuronal motility processes
has been investigated in greater detail than its TCF and MRTF
cofactors.
The elucidation of SRF functions in neurons has been greatly
aided by the availability of Srf mouse mutants (Wiebel et al., 2002;
Alberti et al., 2005). Conditional Srf ablation, e.g., in the murine
forebrain revealed awealthof neuronalmotility phenotypes (Knoll
and Nordheim, 2009).
In early postnatal stages, SRF ablation resulted in impaired tan-
gential cell migration along the rostral migratory stream (Alberti
et al., 2005). Besides cell migration, neurite outgrowth, axon
vs. dendrite differentiation, and axon guidance of hippocampal
and sensory axons were disturbed in Srf mutants (Knoll et al.,
2006; Wickramasinghe et al., 2008; Stern et al., 2009). In the
hippocampus of SRF-deﬁcient mice, mossy ﬁber axon guidance
was impaired (Knoll et al., 2006). SRF-deﬁcient neurons are fre-
quently bipolar in shape and reduced in neurite length (Knoll
et al., 2006; Stern et al., 2009; Stritt and Knoll, 2010). In SRF-
deﬁcient mice primary hippocampal or dorsal root ganglia (DRG)
neurons, neurite outgrowth is severely impaired (Knoll et al.,
2006; Wickramasinghe et al., 2008). Conversely, overexpression
of constitutively active SRF–VP16 enhanced neurite outgrowth
in wild-type (Wickramasinghe et al., 2008) and was more pro-
nounced in neuronswith SRF-deﬁciency (Knoll et al., 2006). Thus,
in general terms, SRF loss-of-function (LOF) decreases neurite
growth. SRF gain-of-function (GOF), e.g., by overexpression of
SRF–VP16, stimulates neurite extension (Table 1). The latter ﬁnd-
ing is of potential relevance in axonal regeneration (see SRF and
Cofactors in Pathological Neuronal Motility and Potential SRF
and Cofactor Invoked Mechanisms Modulating Neurite Growth
and Regeneration.).
Growth cones of SRF-deﬁcient neurons do not protrude ﬁnger-
like ﬁlopodia and therefore appear rounded in shape (Knoll et al.,
2006; Stern et al., 2009) (Figure 1). Notably, retraction bulbs,
the growth cone equivalent of transected CNS axons, are likewise
rounded-up and frequently also protrude fewer ﬁlopodia (Erturk
et al., 2007) (Figure 1). Stimulation of growth cone cytoskeletal
dynamics with axon guidance cues, such as ephrins (Knoll and
Drescher, 2002), results in a transient de-polymerization of the
cytoskeleton, the so-called growth cone collapse response (Dent
and Gertler, 2003; Pak et al., 2008). The growth cone collapse is
thought to allow for directional re-orientation of axons ensuring
appropriate axonal target selection in vivo. However, in Srf mutant
neurons, actin, (and microtubule) cytoskeletal rearrangements
upon guidance cue application failed. This resulted in aberrant
growth cone structures consistingof F-actin andmicrotubule ring-
like ﬁlaments (Knoll et al., 2006; Stern et al., 2009) (Figure 1).
Similar results were also observed in endothelial cells lacking SRF,
arguing for an SRF function on cytoskeletal dynamics conserved
in various cell types (Franco and Li, 2009).
Serum response factor ablation in the adult nervous system
revealed essential SRF functions in neuronal activity-induced gene
expression, synaptic plasticity, learning, and memory (Ramanan
et al., 2005; Etkin et al., 2006). Here, the IEG Arc, also possess-
ing actin cytoskeleton modulatory properties (Messaoudi et al.,
2007), emerges as important SRF andMRTF controlled target gene
(Kawashima et al., 2009;Pintchovski et al., 2009; Smith-Hicks et al.,
2010). Such an SRF-Arc regulatory unit might be instrumental in
structural alterations of synapse function (e.g., spine growth and
shape).
MRTF FUNCTIONS IN NEURONAL MOTILITY
In vivo function of MRTFs in the brain have recently been
investigated employing Mrtf-a/Mrtf-b compound mouse mutants
(Mokalled et al., 2010). Srf and Mrtf double mutants share
many neuronal phenotypes, suggesting that SRF might mediate
many of its functions by MRTF recruitment. Similar to neu-
rons lacking SRF (see SRF Functions in Neuronal Motility),
MRTF-A/MRTF-B deﬁcient neurons revealed decreased neurite
outgrowth (Mokalled et al., 2010). This is in line with overex-
pression of dominant-negative MRTF-A in primary hippocampal
neurons resulting likewise in decreased neurite growth (Knoll
et al., 2006; Shiota et al., 2006). In addition, MRTF-B overex-
pression or knock-down stimulates and reduces neurite com-
plexity of primary neurons, respectively (Ishikawa et al., 2010;
O’sullivan et al., 2010). In contrast MRTF-A knock-down resulted
in enhanced neurite complexity, which might be explained by
concomitant induction of MRTF-B expression (O’sullivan et al.,
2010).
In sum, all data available so far point at a neurite outgrowth
promoting function of MRTFs.
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Table 1 | Summary of effects imposed on neuronal morphology upon SRF, MRTF andTCF loss of-function (LOF) and gain-of-function (GOF).
SRF MRTF TCF
LOF GOF LOF GOF LOF GOF
Effect on
neuronal
morphology
(i) Decreased
neurite
outgrowth
(i) Increased
neurite
outgrowth
(i) Decreased neurite
outgrowth and dendritic
complexity
(i) Enhanced
dendritic
complexity
Reduced
dendritic
length
(i) Enhanced
dendritic length
(ii) Impaired
growth cone
morphology
(ii) Increased
neurite branching
(ii) Enhanced
neuronal differen-
tiation
(iii) Enhanced cell
death
Method Conditional
murine Srf
inactivation
Overexpression
of SRF–VP16
(i) Murine Mrtf-a/Mrtf-b
inactivation
(i) MRTF-B
overexpres-
sion
Overexpression
of dom.-neg.
Elk-1
(i) Overexpression
of const.-active
Elk-1
(ii) siRNA mediated
knock-down
(ii) Overexpres-
sion of wt Elk-1 or
sElk-1
(iii) Overexpression of
dom.-neg. MRTF-A
(iii) Elk-1 overex-
pression in den-
drites only
Cell type Hippocampal,
DRG
Hippocampal,
DRG
Hippocampal, cortical, DRG Cortical Striatal (i) Striatal
(ii) PC12 cells
(iii) Hippocampal
Reference Knoll et al.
(2006), Wickra-
masinghe
et al. (2008)
Knoll et al. (2006),
Wickramasinghe
et al. (2008), Stritt
and Knoll (2010)
Ishikawa et al. (2010), Knoll
et al. (2006), Shiota et al.
(2006), Wickramasinghe et al.
(2008), O’sullivan et al. (2010),
Mokalled et al. (2010)
Ishikawa et al.
(2010)
Lavaur et al.
(2007)
Vanhoutte et al.
(2001), Barrett
et al. (2006a),
Lavaur et al.
(2007)
FIGURE 1 | Comparison of SRF-deficient growth cones with retraction
bulb. (A) Scheme of a growth cone of a wild-type neuron grown in cell
culture. The growth cone typically protrudes multiple ﬁnger-like ﬁlopodia
(one is marked by an arrow). (B) A growth cone derived from an
SRF-deﬁcient neuron grown in culture. Please note the reduced number of
ﬁlopodia resulting in a round shape of the growth cone. (C) A so-called
retraction bulb, typically found at the end of a transected axon of a
wild-type neuron in vivo. Similar to SRF-deﬁciency (B), retraction bulbs
elaborate fewer ﬁlopodia. Schematic drawing is based on a ﬁgure from
Erturk et al. (2007).
TCF FUNCTIONS IN NEURONAL MOTILITY
Data available reveal a function of the TCF family member Elk-
1 in neurite outgrowth and – of potential relevance for axonal
regeneration – also in neuronal survival/apoptosis (Sgambato
et al., 1998; Vanhoutte et al., 2001; Barrett et al., 2006a,b; Lavaur
et al., 2007;Demir et al., 2009, 2011; Besnard et al., 2011; see Poten-
tial SRF and Cofactor Invoked Mechanisms Modulating Neurite
Growth and Regeneration). An additional feature of TCFs shared
by MRTFs, yet not SRF, is a potential nuclear-to-cytoplasmic shut-
tling of these gene regulators (Besnard et al., 2011). Wild-type
Elk-1, in contrast to a shorter neuron-speciﬁc nucleus-restricted
Elk-1 isoform (sElk-1), also localizes to the neuronal cytoplasm
(Sgambato et al., 1998; Vanhoutte et al., 2001). Upon stimu-
lation however, activated, i.e., phosphorylated Elk-1 appears to
re-localize exclusively to the nucleus in vitro. However, in vivo
neuronal activation resulted in both constitutive nuclear P-Elk-
1 accumulation but also additional cytoplasmic signals (Lavaur
et al., 2007). Thus, cytoplasmic vs. nuclear Elk-1 localizationmight
also differentially inﬂuence neurite outgrowth. Indeed, nucleus-
restricted sElk-1 enhanced the percentage of neuronal-like PC12
cell with neurites (Vanhoutte et al., 2001). Contrastingly, target-
ing Elk-1 overexpression speciﬁcally to the dendrites, resulted in
decreased neuronal survival of primary neurons (Barrett et al.,
2006a). Overexpression of dominant-negative or constitutively
activeElk-1 resulted inElk-1 localizationprimarily in thedendrites
and nucleus of primary neurons, respectively. Whereas dominant-
negative Elk-1 reduced dendritic length, the constitutively active
Elk-1 enhanced dendritic length (Lavaur et al., 2007).
So far,TCF analysis in neurons in vivo failed to uncover essential
TCF functions in the brain as detailed for SRF and MRTFs above.
Investigations of TCF functions are hampered by an apparent
functional redundancy among the three main family members.
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Elk-1 mouse mutants reveal no obvious neuronal phenotype
besides a mildly impaired IEG response in the hippocampus
(Cesari et al., 2004).
In sum, Elk-1 modulates neuronal motility most likely in a
sub-cellular compartment dependent manner.
SRF AND COFACTORS IN PATHOLOGICAL NEURONAL
MOTILITY
As described in detail above (see SRF and Its Cofactors in
Physiological Processes Requiring Neuronal Motility), SRF and
cofactors were assigned various functions in shaping neuronal
morphology including neurite growth, branching and growth
cone shape. Many neurological disorders affect neuronal motil-
ity. Chronic seizures for instance, induce exuberant sprouting of
mossy ﬁbers emanating from dentate gyrus granule cell neurons.
In contrast to this excessive outgrowth of new neurites during
status epilepticus, axotomy in the central nervous system, e.g.,
during spinal cord injury, prevents re-growth of severed nerve
ﬁbers.
Due to its intimate link with actin cytoskeletal dynamics,
activity of SRF and cofactors might be targeted during such
neuro-pathological processes of neuronal motility. Particularly,
the potential of SRF–VP16 to stimulate neurite outgrowth (Knoll
et al., 2006;Wickramasinghe et al., 2008) and branching (Stritt and
Knoll, 2010) of primary neurons might proof valuable for speed-
ing up re-growth and branching of transected axons. In recent
years, expression and/or functions of SRF and cofactors has been
reported in the course of many neuro-pathological conditions.
These include Alzheimer’s disease (Chow et al., 2007; Bell et al.,
2009; Sharma et al., 2010), Huntington’s disease (Sharma et al.,
2010), epilepsy (Herdegen et al., 1997a; Morris et al., 1999; Hu
et al., 2004), de-myelination (Stritt et al., 2009), retinal degenera-
tion (Sandstrom et al., 2011), hyperactivity (Parkitna et al., 2010),
hypoxia (Jiang et al., 2009; Cao et al., 2011), resilience to chronical
stress (Vialou et al., 2010), and alcohol addiction (Paul et al., 2010).
However so far, functional data of SRF or one of its cofactors in
axonal regeneration are not available. Yet looking at regeneration
processes in other organs, SRF has already been implicated in,
e.g., ulcer healing, muscle, and hepatocyte regeneration (Chai and
Tarnawski, 2002).
Interestingly, most data on roles of SRF and its cofactors in
axonal injury available so far are derived from investigations focus-
ing on TCFs, namely Elk-1. This might be due to the intimate
link of TCFs such as Elk-1 and induction of an IEG response
upon axonal injury (see Potential SRF and Cofactor Invoked
Mechanisms Modulating Neurite Growth and Regeneration).
As indicated above, so far functional data on SRF and cofac-
tors in axonal regeneration are not reported. However, expression
proﬁles of SRF and TCFs, but not MRTFs, after axonal injury have
been investigated (Herdegen and Zimmermann, 1995; Herdegen
et al., 1997a; Lin et al., 2003; Hu et al., 2004; Sung et al., 2004;
Perlson et al., 2005; Kerr et al., 2010).
In a ﬁrst study, Perlson et al. (2005) demonstrated up-
regulation of activated Elk-1 (P-Elk-1) in the nucleus within
10 min afterDRGneuron axotomy.Notably, this P-Elk-1 induction
was abolished in mice lacking the intermediate ﬁlament vimentin
(Perlson et al., 2005). This increase in P-Elk-1 is most likely not
due to novel Elk-1 mRNA synthesis, as recently demonstrated
(Kerr et al., 2010). In this study, mRNA levels of various TCF
family members were analyzed upon sciatic nerve lesion. Whereas
Net (Elk-3) mRNA expression was strongly induced upon lesion,
Elk-1 mRNA abundance remained unaltered. The induction of
nucleus-restricted P-Elk-1 on protein level observed in lesioned
DRG neurons (Perlson et al., 2005) was conﬁrmed in a mouse
model of traumatic brain injury in the hippocampal system (Hu
et al., 2004). Further, elevated P-Elk-1 levels were observed in an
Aplysia model of nerve crush (Lin et al., 2003; Sung et al., 2004).
These ﬁndings suggests that Elk-1 activity in injured neurons
is mainly regulated by post-translational, i.e., phosphorylation,
rather than transcriptional mechanisms.
A ﬁrst study analyzing both Elk-1 and SRF in neuronal injury
was provided by Lin et al. (2003). Here, the authors provide data
arguing for occupancy of a c-fos derived SRE by Elk-1 and SRF
in both injured pleuropedal Aplysia and mouse DRG neurons. In
contrast to DRG neurons, altered SRF expression was not found
in other peripheral neuron lesion models including the optic and
facial nerve (Herdegen et al., 1997a).
In sum, although far from being complete, data available so far
mainly focusing on peripheral nerve injury indicate that Elk-1 and
also SRF activity are targeted by axonal transection. Future studies
will have to address SRF and cofactor expression also in central
axon injury models. In addition, it will be important to expand
analysis to various (short and longer) time-points after injury also
including additional SRF and cofactor anti-sera.
POTENTIAL SRF AND COFACTOR INVOKED MECHANISMS
MODULATING NEURITE GROWTH AND REGENERATION
Serum response factor and cofactors can potentially regulate a
wealth of different target genes, depending on, e.g., cell and stimu-
lus type. As outlined above (see Introduction), SRF-mediated gene
regulation has been analyzed in greatest depth in the IEG response
and for genes encoding components of the actin cytoskeleton.
Therefore, I will propose potential mechanism by which SRF and
cofactors might modulate neuronal motility involving IEGs and
cytoskeletal gene products.
IEG ACTIVATION AND NEURONAL FUNCTIONS
The induction of IEGs, primarily those encoding transcriptional
regulators such as c-Jun, by axonal injury is a well-established
response observed in various neuronal populations (Morgan et al.,
1987; Haas et al., 1993; Hull and Bahr, 1994; Curran and Mor-
gan, 1995; Robinson, 1995; Herdegen et al., 1997a,b; Herdegen
and Leah, 1998; Herdegen and Waetzig, 2001; Moran and Grae-
ber, 2004; Raivich et al., 2004; Raivich and Behrens, 2006; Raivich,
2008). Besides changes in expression level, individual IEGs such
as c-Jun are indispensable for peripheral axon regeneration, e.g.,
of facial motor neurons (Raivich et al., 2004). IEG induction is
rapid, yet transient, suggesting an involvement of IEGs in early
stages of neuronal differentiation and axonal injury processes.
Of note, many IEGs encode transcription factors (c-Fos, Egr-1,
Egr2, Fosb, JunB, c-Jun) under SRF-mediated gene transcrip-
tion (Posern and Treisman, 2006; Knoll and Nordheim, 2009;
Olson and Nordheim, 2010). Thus, a hierarchical cascade of gene
regulators with SRF acting upstream of IEGs might operate and
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FIGURE 2 | Serum response factor signaling in neuronal motility.
Summary of potential upstream signaling cascades activating SRF and/or
TCF/MRTF cofactor activity. In addition, possible scenarios on the impact of
SRF-mediated gene transcription on neuronal differentiation and axonal
regeneration are provided. The latter include regulation of cell survival (e.g.,
via IEGs, neurotrophin, and insulin growth factors) and cytoskeletal
dynamics. Here, SRF and most likely MRTFs will adjust mRNA levels of
genes encoding cytoskeletal genes (gelsolin, actin isoforms, etc.) and
modulate activity of the actin severing protein coﬁlin. Further, SRF might
adjust Rho-GTPase activity and thereby modulate actin (and microtubule)
polymerization.
diverge the single axonal injury signal into various gene expression
programs.
How might IEGs, transcriptionally regulated, e.g., via an SRF–
TCF transcription complex,contribute tophysiological andpatho-
logical neuronal motility? IEGs are well-established regulators of
both, neuronal apoptosis and cell survival (Chen et al., 1995;
Herdegen and Leah, 1998; Hughes et al., 1999; Raivich, 2008;
Durchdewald et al., 2009). Thus, depending on, e.g., neuron type,
severity of lesion applied (e.g., crush vs. complete transection), and
time-point after injury, IEGs might induce cell death or enhance
survival of injured motorneurons (Figure 2). In line with such
an IEG function, TCFs have been implicated as regulators of
neuronal apoptosis in vitro. Overexpression of Elk-1 in primary
neurons triggered cell death (Barrett et al., 2006a,b), a func-
tion involving an association of Elk-1 with mitochondria (Barrett
et al., 2006b). In contrast, Demir et al. (2011) recently demon-
strated that Elk-1 overexpression in PC12 cells had a pro-survival
effect. This discrepancy might be due to cell type speciﬁc Elk-1
effects and – importantly – a sub-cellular compartment speciﬁc
Elk-1 function. The latter is supported by ﬁndings demonstrat-
ing that overexpression of Elk-1 restricted to dendrites, but not in
the nucleus, was able to induce cell death (Barrett et al., 2006a).
Thus, the sub-cellular localization of TCFs such as Elk-1 upon
axonal injury might be decisive in regulation of a potential sur-
vival or pro-apoptotic TCF function in, e.g., axonal regeneration.
In such a scenario, Elk-1 might contribute to axonal regeneration
not only by a nuclear but also by a cytoplasmic function.
Serum response factor (Chang et al., 2004) and MRTF (Cao
et al., 2011) overexpression protects neurons from cell death in
cell culture. In contrast, in vivo no major SRF contribution to
regulation of neuronal cell survival and apoptosis during brain
development and physiological function has been reported (Knoll
and Nordheim, 2009).
Besides apoptosis/cell survival, IEGs such as Egr-1, c-Fos and
c-Jun may directly modulate neurite outgrowth in vitro (Jessen
et al., 2001; Levkovitz et al., 2001; Eminel et al., 2008). However,
enhanced neurite outgrowth might be coupled with or as a con-
sequence of a potential pro-survival IEG function. In addition,
the IEG Arc – also controlling actin cytoskeletal dynamics – is
regulated by synaptic activity (Plath et al., 2006; Smith-Hicks
et al., 2010) summarized in (Shepherd and Bear, 2011). Thus,
SRF-controlled IEGs might not only contribute to early phases of
axonal regeneration when survival/cell death decisions are made,
but also at later stages, e.g., during synaptic targeting and function
of successfully regenerated axons.
CYTOSKELETAL DYNAMICS AND NEURONAL MOTILITY
Along with microtubules, actin is a major cytoskeletal compo-
nent involved during neuronal motility (Dent and Gertler, 2003;
Pak et al., 2008; Tahirovic and Bradke, 2009). In contrast to
microtubules (Erturk et al., 2007) which have been extensively
investigated in retraction bulbs of injured axons in vivo, the actin
cytoskeleton has not been analyzed so far in the same depth. Also,
whereas interference with microtubule function enhances axonal
regeneration in vivo (Hellal et al., 2011), depletion of the major
neuronal actin variant β-actin did not affect motor axon regenera-
tion in vivo (Cheever et al., 2011). In line with this, overexpression
of β-actin in SRF-deﬁcient neurons alone was not sufﬁcient to
rescue neurite outgrowth (Knoll et al., 2006). This might suggest
that ABPs and/or other actin isoforms (e.g., α-actin or γ-actin)
are more crucial for neurite outgrowth and axonal regenera-
tion processes. Indeed, actin isoforms (Tetzlaff et al., 1988, 1991;
Mizobuchi et al., 1990; Tetzlaff and Bisby, 1990; Bisby and Tetzlaff,
1992; Lund and Mcquarrie, 1996; Riley and Bernstein, 1996; Lund
et al., 2002; Avwenagha et al., 2003; Moran and Graeber, 2004;
Willis et al., 2005) and ABPs such as thymosin (Mollinari et al.,
2009), myosins (Jian et al., 1996), GAP-43 (Tetzlaff et al., 1991;
Avwenagha et al., 2003), integrins (Werner et al., 2000), and, e.g.,
coronins (Di Giovanni et al., 2005) are up-regulated upon axonal
injury in various instances. Myosin expression has been shown
to overcome in vitro neurite outgrowth barriers associated with
axonal regeneration (Kubo et al., 2008). As genes encoding myosin
components are SRF-regulated (Knoll and Nordheim, 2009;Olson
and Nordheim, 2010), SRF might contribute to neurite outgrowth
processes in development and pathology by transcriptional reg-
ulation of myosin and other promoters regulating expression of
actin associated genes (Figure 2).
Besides transcriptional regulation, SRF can modulate activity
of the actin severing proteins coﬁlin and gelsolin (Alberti et al.,
2005; Mokalled et al., 2010). Elevated P-coﬁlin levels, represent-
ing inactive coﬁlin, were reported in SRF- and MRTF-deﬁcient
neurons (Alberti et al., 2005; Mokalled et al., 2010). This suggests
that wild-type SRF–MRTF signaling activates coﬁlin, amechanism
involving the CDK5 interacting kinase Pctaire1 (Mokalled et al.,
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2010). Coﬁlin is phosphorylated and de-phosphorylated by LIM-
kinases and slingshot phosphatases, respectively (Bernstein and
Bamburg, 2010). Importantly, this LIM-kinase–coﬁlin–slingshot
regulatory unit is crucially involved inneurite outgrowthon regen-
eration inhibiting substrates such as Nogo (Hsieh et al., 2006).
Inactive coﬁlin might prevent actin treadmilling and, e.g., de novo
formation of F-actin ﬁlaments during processes relying on neu-
ronal motility such as neurite outgrowth, branch formation or
growth cone turning. In fact, the presence of inactivated coﬁlin
in SRF-deﬁcient neurons may explain the perseverance of F-actin
positive actin rings in growth cones upon incubation with col-
lapsing agents such as ephrins (Knoll et al., 2006). Thus, adjusting
coﬁlin activity by SRF might emerge as one major mechanism by
which SRF–MRTF can regulate neuronal motility (Figure 2).
In addition, SRF might modulate neuronal motility by inter-
action with signaling molecules positioned upstream of coﬁlin
such as Rho-GTPases. In recruiting downstream effectors such as
Rho-kinase, Rho-GTPases modulate the actin cytoskeleton, and –
importantly – also microtubules. Rho-GTPases are well-known
activators of SRF activity (Hill et al., 1995; Posern and Treis-
man, 2006; Olson and Nordheim, 2010). In turn, SRF-deﬁciency
altered Rho-GTPase activity (Stritt and Knoll, 2010), suggesting
a tight regulatory loop between Rho-GTPases and SRF. Rho-
GTPases, particularly RhoA are well-known downstream effectors
mediating the growth inhibitory potential of Nogo, MAG and
other myelin associated regeneration inhibitors (Filbin, 2003; Yiu
and He, 2006). In addition, Rho-GTPases modulate neuronal
motility, e.g., neurite outgrowth and polarization (Govek et al.,
2005; Tahirovic and Bradke, 2009; Hall and Lalli, 2010). Thus,
although data are currently not available, it might be tempting
to speculate that Rho-GTPases interact with SRF-mediated tran-
scription during physiological and regenerative neuronal motil-
ity processes (Figure 2). As so far, MRTFs have been shown to
connect Rho-GTPase–actin with SRF signaling, it is likely that
MRTFs are the crucial cofactors teaming up with SRF during these
functions.
SRF’s IMPACT ON GROWTH FACTOR SIGNALING IN NEURONAL
MOTILITY
Many growth factors modulate neurite outgrowth and axonal
regeneration. With regard to neuronal SRF-mediated transcrip-
tional regulation, two growth factor signaling pathways might
proof important for conveying SRF’s impact on neuronal motility.
First, neurotrophins such as BDNF and NGF activate SRF-
mediated transcription (Chang et al., 2004; Kalita et al., 2006;
Wickramasinghe et al., 2008; Stritt and Knoll, 2010) and SRF
expression (Kalita et al., 2006). Data available so far suggest
a recruitment of MAP kinases upon neurotrophin signaling to
activate SRF.As neurotrophins are implicated in neuronal survival,
neurite outgrowth, growth cone morphology, and axonal regen-
eration (Gallo and Letourneau, 2004; Lykissas et al., 2007), SRF,
and cofactors might be targeted by signaling cascades triggered by
neurotrophins. Additionally, Bdnf mRNA levels were reduced in
Srf mutant neurons, suggesting induction of the Bdnf promoter by
wild-type SRF (Etkin et al., 2006). Thus, SRF might be employed
to adjust BDNF levels available to neurons and thereby inﬂuence
axonal injury (Figure 2).
Secondly, SRF emerges as transcriptional regulator of many
genes encoding components of insulin or insulin growth factor
(IGF) signaling in neurons and non-neuronal cells. These genes
include the insulin gene (Sarkar et al., 2011), Igf1 (Charvet et al.,
2006; Sun et al., 2009), and, e.g., Ctgf, a protein harboring an IGF
binding domain (Stritt et al., 2009). Such SRF-mediated control of
insulin/IGF regulation in neurons was also demonstrated to affect
neighboring cells, i.e., oligodendrocytes, in a paracrine manner
(Stritt et al., 2009). In addition, insulin signaling augmented TCF
occupancy at SREs (Thompson et al., 1994) and insulin resistance
in muscles is associated with altered SRF–MRTF activity (Jin et al.,
2011). Notably, insulin/IGF signaling regulates neurite outgrowth
(Ozdinler and Macklis, 2006) and can increase regeneration prop-
erties of transected axons (Near et al., 1992; Ishii et al., 1994; Fu
and Gordon, 1997). SRF might also be connected to glial scar for-
mation, a major physical barrier of CNS axon regeneration. This
might be accomplished by regulation of CTGF (connective tissue
growth factor) levels, a secreted protein associatedwith ﬁbronectin
function and scar formation (Hertel et al., 2000; Conrad et al.,
2005).
In sum, SRF gene regulation might modulate insulin/IGF sig-
naling during physiological neuronal motility processes as well as
in injured neurons (Figure 2).
OUTLOOK
Wild-type SRF and cofactors can modulate many mechanisms
such as an IEG response, actin cytoskeletal dynamics, and growth
factor signaling which contribute to neuronal motility in devel-
opment and, e.g., axonal injury. Future experiments will have to
address directly, e.g., employing conditional Srf or Mrtf mutagene-
sis or TCF compound mutants, whether SRF and cofactors are key
players in axonal regeneration. In this regard, performing GOF
experiments employing SRF–VP16, a known in vitro stimulator
of neurite outgrowth, in in vivo axonal regeneration paradigms
might be particularly rewarding.
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